At QuitCig we developed, as team of 3 co-founders, a pioneering medical technology targeted to quit nicotine addiction with limited withdrawal symptoms. It combined a sophisticated nicotine decrease algorithm embedded on an inhaler, similar to an electronic cigarette. The optimal nicotine decrease rate was set by a machine learning algorithm controlling the evaporation. A partnership was built up with University Hospital of Zurich.
Company’s Keywords:
<0
<
<
<2016
Your request has been submitted successfully.
Own or work here?